Federal Register Final rule: FDA is classifying norovirus serological reagents into Class 2 (special controls) with a guidance document serving as the special control, Class II Special Controls Guidance Document: Norovirus Serological Reagents. To download this guidance, click here. To view this final rule, click here.
